Recommended

FSCS-Piggy-Bank-500x320.jpg

Arck investors face further FSCS claim delays

Investors in failed property investment scheme Arck are facing further delays as the Financial Services Compensation Scheme continues to investigate claims against advisers. In an update published on its website yesterday, the FSCS says it has moved “a step closer” to assessing the scheme’s financial position in relation investors’ claims after former Arck partners Kathryn […]

Phil Young

My beautiful career: Phil Young

What was your first job in financial services? I worked for a small consultancy business in Macclesfield, mainly focusing on compliance. It wasn’t always fun but I learned a lot about what good looks like. Describe your current role. I am managing director of threesixty. I spend most of my time talking to advisers, figuring […]

Kellard Mike Axa Wealth 700x450

Record inflows push Axa Elevate to £10bn

Record new money in March has helped push Axa Elevate’s funds under management to £10bn, Axa Wealth’s quarterly results show. The platform saw £534m of new assets in the first quarter of 2015, with funds under management rising 26 per cent year-on-year, from £7.9bn in 2014 to £10bn. An 8 per cent increase in pension […]

bondsgraph

Investment analysis: Are we seeing a strange new world for the bond market?

The combination of low inflation growth and excess liquidity following the ECB’s quantitative easing programme has distorted bond valuations, with some short-duration instruments now offering negative returns. At the beginning of March nearly $3.85trn (£2.56trn) or 17 per cent of developed market global government bonds traded at negative yields, according to Columbia Threadneedle Investments. In […]

State of the markets: UK equity income

Artemis Income Fund manager Nick Shenton discusses the state of the UK equity income market with journalist Alexis Xydias. With the first three months of 2015 showing strong returns for both the Artemis Income Fund and UK markets generally, Nick Shenton discusses the fund’s top contributors – including overseas holdings Novartis and Bayer – and […]

Newsletter

News and expert analysis straight to your inbox

Sign up

Comments

    Leave a comment